Prostaglandin E2-d4-1-glyceryl ester

莫西沙星杂质S;莫西沙星杂质275

Prostaglandin E2-d4-1-glyceryl ester

1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;Moxifloxacin impurity 26/1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride;Moxifloxacin-17;Moxifloxacin Impurity S;3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-8-methoxy-6-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-;1-?Cyclopropyl-?7-?fluoro-?1,?4-?dihydro-?8-?methoxy-?6-?[(4aS,?7aS)?-?octahydro-?6H-?pyrrolo[3,?4-?b]?pyridin-?6-?yl]?-?4-?oxo-3-?quinolinecarboxylic acid;Azilsartan medoxomil impurity275

2205053-60-5

C₂₁H₂₄FN₃O₄

401.43

Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Neuroscience|Cannabinoid Research